Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
12,602,265
-
Total 13F shares
-
6,459,357
-
Share change
-
+363,887
-
Total reported value
-
$306,655,798
-
Put/Call ratio
-
20%
-
Price per share
-
$47.47
-
Number of holders
-
117
-
Value change
-
+$17,489,557
-
Number of buys
-
64
-
Number of sells
-
43
Institutional Holders of IRADIMED CORP - Common (IRMD) as of Q4 2023
As of 31 Dec 2023,
IRADIMED CORP - Common (IRMD) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,459,357 shares.
The largest 10 holders included
Nine Ten Capital Management LLC, BlackRock Inc., Soleus Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, RK Capital Management, LLC, Bares Capital Management, Inc., Ranger Investment Management, L.P., Russell Investments Group, Ltd., and DIMENSIONAL FUND ADVISORS LP.
This page lists
117
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.